2024-2028年单采设备的全球市场
市场调查报告书
商品编码
1464541

2024-2028年单采设备的全球市场

Global Apheresis Devices Market 2024-2028

出版日期: | 出版商: TechNavio | 英文 169 Pages | 订单完成后即时交付

价格

预计2023-2028年单采设备市场将成长15.9亿美元,预测期内复合年增长率为8.45%。

该报告包括对单采设备市场的总体分析、市场规模和预测、趋势、成长驱动因素、挑战以及涵盖约 25 家供应商的供应商分析。

它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。血浆产品新适应症的增加、慢性病盛行率的增加以及与创伤和伤害病例相关的外科手术的增加推动了市场的发展。

市场范围
基准年 2024年
结束年份 2028年
预测期 2024-2028
成长动力 加速度
2024年与前一年同期比较 7.22%
复合年增长率 8.45%
增量 15.9亿美元

这项研究将全球单采设备市场的开拓视为未来几年推动单采设备市场成长的关键因素之一。此外,单采术向以患者为中心的护理模式的转变以及单采术设备的技术进步将带来巨大的市场需求。

目录

第一章执行摘要

  • 市场概况

第二章 市场状况

  • 市场生态系统

第三章 市场规模评估

  • 市场定义
  • 细分市场分析
  • 2023 年市场规模
  • 2023-2028年市场展望

第四章 市场规模表现

  • 2018-2022年全球单采设备市场
  • 2018-2022年产品細項分析
  • 2018-2022 年按应用分類的细分市场分析
  • 2018-2022 年区域細項分析
  • 2018-2022 年国家細項分析

第五章五力分析

  • 五力摘要
  • 买方议价能力
  • 供应商的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争威胁
  • 市场状况

第六章市场区隔:依产品

  • 细分市场
  • 比较:按产品
  • 系统:2023-2028年市场规模及预测
  • 消耗品:2023-2028 年市场规模与预测
  • 市场机会:依产品分类

第七章市场区隔:按应用

  • 细分市场
  • 比较:按应用
  • 神经系统疾病:2023-2028 年市场规模与预测
  • 血液疾病:2023-2028 年市场规模与预测
  • 肾臟疾病:2023-2028 年市场规模与预测
  • 自体免疫疾病:2023-2028年市场规模与预测
  • 市场机会:依应用分类

第八章 客户状况

  • 客户状况概览

第九章 地区情势

  • 区域细分
  • 区域比较
  • 北美:2023-2028 年市场规模与预测
  • 欧洲:2023-2028 年市场规模与预测
  • 亚洲:2023-2028年市场规模与预测
  • 世界其他地区:2023-2028 年市场规模与预测
  • 美国:2023-2028 年市场规模与预测
  • 德国:2023-2028年市场规模与预测
  • 加拿大:2023-2028 年市场规模与预测
  • 英国:2023-2028 年市场规模与预测
  • 中国:2023-2028年市场规模及预测
  • 市场机会:依地区状况

第 10 章 驱动因素、挑战与趋势

  • 市场驱动因素
  • 市场挑战
  • 驱动因素和挑战的影响
  • 市场趋势

第十一章 供应商情况

  • 概述
  • 供应商情况
  • 混乱的情况
  • 产业风险

第十二章供应商分析

  • 交易厂商
  • 供应商市场定位
  • Asahi Kasei Corp.
  • B.Braun SE
  • BioIVT LLC
  • Cerus Corp.
  • Charles River Laboratories International Inc.
  • Fresenius Medical Care AG and Co. KGaA
  • Haemonetics Corp.
  • Haier Smart Home Co. Ltd.
  • Kaneka Corp.
  • Kawasumi Laboratories Inc.
  • Lmb Technologie GmbH
  • Mallinckrodt Plc
  • Medica SpA
  • Miltenyi Biotec BV and Co. KG
  • Nikkiso Co. Ltd.

第十三章附录

Product Code: IRTNTR40157

The apheresis devices market is forecasted to grow by USD 1.59 bn during 2023-2028, accelerating at a CAGR of 8.45% during the forecast period. The report on the apheresis devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth in new indications for plasma products, increasing prevalence of chronic diseases, and a growing number of surgical procedures associated with trauma and injury cases.

Technavio's apheresis devices market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20247.22%
CAGR8.45%
Incremental Value$1.59bn

By Product

  • Systems
  • Consumables

By Application

  • Neurological disorders
  • Haematological disorders
  • Renal disorders
  • Autoimmune disorders

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the developments in the global apheresis devices industry as one of the prime reasons driving the apheresis devices market growth during the next few years. Also, the shift towards patient-centric care models in apheresis and technological advances in apheresis devices will lead to sizable demand in the market.

The report on the apheresis devices market covers the following areas:

  • Apheresis devices market sizing
  • Apheresis devices market forecast
  • Apheresis devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading apheresis devices market vendors including Asahi Kasei Corp., B.Braun SE, BioIVT LLC, Braun and Co. Ltd., Charles River Laboratories International Inc., Fresenius Medical Care AG and Co. KGaA, Haemonetics Corp., Haier Smart Home Co. Ltd., Kaneka Corp., Lmb Technologie GmbH, Mallinckrodt Plc, Medica S.p.A., MICRO TECHNOLOGIES, Miltenyi Biotec B.V. and Co. KG, Nikkiso Co. Ltd., OTSUKA ELECTRONICS CO. LTD, Kawasumi Laboratories Inc., Terumo Corp., and Cerus Corp. Also, the apheresis devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview

2 Market Landscape

  • 2.1 Market ecosystem

3 Market Sizing

  • 3.1 Market definition
  • 3.2 Market segment analysis
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

  • 4.1 Global apheresis devices market 2018 - 2022
  • 4.2 Product Segment Analysis 2018 - 2022
  • 4.3 Application Segment Analysis 2018 - 2022
  • 4.4 Geography Segment Analysis 2018 - 2022
  • 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

  • 5.1 Five forces summary
  • 5.2 Bargaining power of buyers
  • 5.3 Bargaining power of suppliers
  • 5.4 Threat of new entrants
  • 5.5 Threat of substitutes
  • 5.6 Threat of rivalry
  • 5.7 Market condition

6 Market Segmentation by Product

  • 6.1 Market segments
  • 6.2 Comparison by Product
  • 6.3 Systems - Market size and forecast 2023-2028
  • 6.4 Consumables - Market size and forecast 2023-2028
  • 6.5 Market opportunity by Product

7 Market Segmentation by Application

  • 7.1 Market segments
  • 7.2 Comparison by Application
  • 7.3 Neurological disorders - Market size and forecast 2023-2028
  • 7.4 Haematological disorders - Market size and forecast 2023-2028
  • 7.5 Renal disorders - Market size and forecast 2023-2028
  • 7.6 Autoimmune disorders - Market size and forecast 2023-2028
  • 7.7 Market opportunity by Application

8 Customer Landscape

  • 8.1 Customer landscape overview

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • 9.2 Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • 9.4 Europe - Market size and forecast 2023-2028
  • 9.5 Asia - Market size and forecast 2023-2028
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • 9.7 US - Market size and forecast 2023-2028
  • 9.8 Germany - Market size and forecast 2023-2028
  • 9.9 Canada - Market size and forecast 2023-2028
  • 9.10 UK - Market size and forecast 2023-2028
  • 9.11 China - Market size and forecast 2023-2028
  • 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • 11.3 Landscape disruption
  • 11.4 Industry risks

12 Vendor Analysis

  • 12.1 Vendors covered
  • 12.2 Market positioning of vendors
  • 12.3 Asahi Kasei Corp.
  • 12.4 B.Braun SE
  • 12.5 BioIVT LLC
  • 12.6 Cerus Corp.
  • 12.7 Charles River Laboratories International Inc.
  • 12.8 Fresenius Medical Care AG and Co. KGaA
  • 12.9 Haemonetics Corp.
  • 12.10 Haier Smart Home Co. Ltd.
  • 12.11 Kaneka Corp.
  • 12.12 Kawasumi Laboratories Inc.
  • 12.13 Lmb Technologie GmbH
  • 12.14 Mallinckrodt Plc
  • 12.15 Medica S.p.A.
  • 12.16 Miltenyi Biotec B.V. and Co. KG
  • 12.17 Nikkiso Co. Ltd.

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • 13.3 Currency conversion rates for US$
  • 13.4 Research methodology
  • 13.5 List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global apheresis devices market 2018 - 2022 ($ billion)
  • Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
  • Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Product - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Product - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Product
  • Exhibits33: Data Table on Comparison by Product
  • Exhibits34: Chart on Systems - Market size and forecast 2023-2028 ($ billion)
  • Exhibits35: Data Table on Systems - Market size and forecast 2023-2028 ($ billion)
  • Exhibits36: Chart on Systems - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Systems - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Consumables - Market size and forecast 2023-2028 ($ billion)
  • Exhibits39: Data Table on Consumables - Market size and forecast 2023-2028 ($ billion)
  • Exhibits40: Chart on Consumables - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Consumables - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Market opportunity by Product ($ billion)
  • Exhibits43: Data Table on Market opportunity by Product ($ billion)
  • Exhibits44: Chart on Application - Market share 2023-2028 (%)
  • Exhibits45: Data Table on Application - Market share 2023-2028 (%)
  • Exhibits46: Chart on Comparison by Application
  • Exhibits47: Data Table on Comparison by Application
  • Exhibits48: Chart on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
  • Exhibits49: Data Table on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
  • Exhibits50: Chart on Neurological disorders - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Neurological disorders - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Chart on Haematological disorders - Market size and forecast 2023-2028 ($ billion)
  • Exhibits53: Data Table on Haematological disorders - Market size and forecast 2023-2028 ($ billion)
  • Exhibits54: Chart on Haematological disorders - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Haematological disorders - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Chart on Renal disorders - Market size and forecast 2023-2028 ($ billion)
  • Exhibits57: Data Table on Renal disorders - Market size and forecast 2023-2028 ($ billion)
  • Exhibits58: Chart on Renal disorders - Year-over-year growth 2023-2028 (%)
  • Exhibits59: Data Table on Renal disorders - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Chart on Autoimmune disorders - Market size and forecast 2023-2028 ($ billion)
  • Exhibits61: Data Table on Autoimmune disorders - Market size and forecast 2023-2028 ($ billion)
  • Exhibits62: Chart on Autoimmune disorders - Year-over-year growth 2023-2028 (%)
  • Exhibits63: Data Table on Autoimmune disorders - Year-over-year growth 2023-2028 (%)
  • Exhibits64: Market opportunity by Application ($ billion)
  • Exhibits65: Data Table on Market opportunity by Application ($ billion)
  • Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits69: Chart on Geographic comparison
  • Exhibits70: Data Table on Geographic comparison
  • Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits97: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits107: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
  • Exhibits109: Impact of drivers and challenges in 2023 and 2028
  • Exhibits110: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits111: Overview on factors of disruption
  • Exhibits112: Impact of key risks on business
  • Exhibits113: Vendors covered
  • Exhibits114: Matrix on vendor position and classification
  • Exhibits115: Asahi Kasei Corp. - Overview
  • Exhibits116: Asahi Kasei Corp. - Business segments
  • Exhibits117: Asahi Kasei Corp. - Key news
  • Exhibits118: Asahi Kasei Corp. - Key offerings
  • Exhibits119: Asahi Kasei Corp. - Segment focus
  • Exhibits120: B.Braun SE - Overview
  • Exhibits121: B.Braun SE - Business segments
  • Exhibits122: B.Braun SE - Key offerings
  • Exhibits123: B.Braun SE - Segment focus
  • Exhibits124: BioIVT LLC - Overview
  • Exhibits125: BioIVT LLC - Product / Service
  • Exhibits126: BioIVT LLC - Key news
  • Exhibits127: BioIVT LLC - Key offerings
  • Exhibits128: Cerus Corp. - Overview
  • Exhibits129: Cerus Corp. - Product / Service
  • Exhibits130: Cerus Corp. - Key offerings
  • Exhibits131: Charles River Laboratories International Inc. - Overview
  • Exhibits132: Charles River Laboratories International Inc. - Business segments
  • Exhibits133: Charles River Laboratories International Inc. - Key news
  • Exhibits134: Charles River Laboratories International Inc. - Key offerings
  • Exhibits135: Charles River Laboratories International Inc. - Segment focus
  • Exhibits136: Fresenius Medical Care AG and Co. KGaA - Overview
  • Exhibits137: Fresenius Medical Care AG and Co. KGaA - Business segments
  • Exhibits138: Fresenius Medical Care AG and Co. KGaA - Key news
  • Exhibits139: Fresenius Medical Care AG and Co. KGaA - Key offerings
  • Exhibits140: Fresenius Medical Care AG and Co. KGaA - Segment focus
  • Exhibits141: Haemonetics Corp. - Overview
  • Exhibits142: Haemonetics Corp. - Business segments
  • Exhibits143: Haemonetics Corp. - Key offerings
  • Exhibits144: Haemonetics Corp. - Segment focus
  • Exhibits145: Haier Smart Home Co. Ltd. - Overview
  • Exhibits146: Haier Smart Home Co. Ltd. - Business segments
  • Exhibits147: Haier Smart Home Co. Ltd. - Key offerings
  • Exhibits148: Haier Smart Home Co. Ltd. - Segment focus
  • Exhibits149: Kaneka Corp. - Overview
  • Exhibits150: Kaneka Corp. - Business segments
  • Exhibits151: Kaneka Corp. - Key offerings
  • Exhibits152: Kaneka Corp. - Segment focus
  • Exhibits153: Kawasumi Laboratories Inc. - Overview
  • Exhibits154: Kawasumi Laboratories Inc. - Product / Service
  • Exhibits155: Kawasumi Laboratories Inc. - Key offerings
  • Exhibits156: Lmb Technologie GmbH - Overview
  • Exhibits157: Lmb Technologie GmbH - Product / Service
  • Exhibits158: Lmb Technologie GmbH - Key offerings
  • Exhibits159: Mallinckrodt Plc - Overview
  • Exhibits160: Mallinckrodt Plc - Business segments
  • Exhibits161: Mallinckrodt Plc - Key offerings
  • Exhibits162: Mallinckrodt Plc - Segment focus
  • Exhibits163: Medica S.p.A. - Overview
  • Exhibits164: Medica S.p.A. - Product / Service
  • Exhibits165: Medica S.p.A. - Key offerings
  • Exhibits166: Miltenyi Biotec B.V. and Co. KG - Overview
  • Exhibits167: Miltenyi Biotec B.V. and Co. KG - Product / Service
  • Exhibits168: Miltenyi Biotec B.V. and Co. KG - Key offerings
  • Exhibits169: Nikkiso Co. Ltd. - Overview
  • Exhibits170: Nikkiso Co. Ltd. - Business segments
  • Exhibits171: Nikkiso Co. Ltd. - Key news
  • Exhibits172: Nikkiso Co. Ltd. - Key offerings
  • Exhibits173: Nikkiso Co. Ltd. - Segment focus
  • Exhibits174: Inclusions checklist
  • Exhibits175: Exclusions checklist
  • Exhibits176: Currency conversion rates for US$
  • Exhibits177: Research methodology
  • Exhibits178: Validation techniques employed for market sizing
  • Exhibits179: Information sources
  • Exhibits180: List of abbreviations